84 related articles for article (PubMed ID: 21691803)
1. Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer.
Elkalioubie A; Allorge D; Robriquet L; Wiart JF; Garat A; Broly F; Fourrier F
Eur J Clin Pharmacol; 2011 Aug; 67(8):855-8. PubMed ID: 21691803
[TBL] [Abstract][Full Text] [Related]
2. Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain.
Casajús A; Zubiaur P; Alday E; Soria-Chacartegui P; Saiz-Rodríguez M; Gutierrez L; Aragonés C; Campodónico D; Gómez-Fernández A; Navares-Gómez M; Villapalos-García G; Mejía-Abril G; Ochoa D; Abad-Santos F
Clin Transl Sci; 2024 Jan; 17(1):e13698. PubMed ID: 38140786
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids.
Knisely MR; Carpenter JS; Draucker CB; Skaar T; Broome ME; Holmes AM; Von Ah D
Appl Nurs Res; 2017 Dec; 38():107-110. PubMed ID: 29241501
[TBL] [Abstract][Full Text] [Related]
4. Transient depersonalisation/derealisation syndrome from tramadol.
Thumtecho S; Wainipitapong S; Tantakitti P
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37280010
[TBL] [Abstract][Full Text] [Related]
5. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol.
Orliaguet G; Hamza J; Couloigner V; Denoyelle F; Loriot MA; Broly F; Garabedian EN
Pediatrics; 2015 Mar; 135(3):e753-5. PubMed ID: 25647677
[TBL] [Abstract][Full Text] [Related]
6. Tramadol Ultra Rapid Metabolizers at Risk for Respiratory Depression.
Dhaliwal G; Hsu D
Pain Physician; 2016 Feb; 19(2):E361. PubMed ID: 26815266
[No Abstract] [Full Text] [Related]
7. Severe Noncardiogenic Pulmonary Edema Secondary to Massive Verapamil Overdose and Treatment with Venovenous Extracorporeal Membrane Oxygenation.
Ho A; Go A; Barrios C; Scalzo A
Case Rep Crit Care; 2020; 2020():8842303. PubMed ID: 33425397
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal Cardiopulmonary Resuscitation After Diphenhydramine Ingestion.
Labarinas S; Meulmester K; Greene S; Thomas J; Virk M; Erkonen G
J Med Toxicol; 2018 Sep; 14(3):253-256. PubMed ID: 29956117
[TBL] [Abstract][Full Text] [Related]
9. Two Cases of Refractory Cardiogenic Shock Secondary to Bupropion Successfully Treated with Veno-Arterial Extracorporeal Membrane Oxygenation.
Heise CW; Skolnik AB; Raschke RA; Owen-Reece H; Graeme KA
J Med Toxicol; 2016 Sep; 12(3):301-4. PubMed ID: 26856351
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of flecainide-induced cardiac arrest with extracorporeal membrane oxygenation in the ED.
Reynolds JC; Judge BS
Am J Emerg Med; 2015 Oct; 33(10):1542.e1-2. PubMed ID: 26299692
[TBL] [Abstract][Full Text] [Related]
11. Life-threatening flecainide overdose treated with intralipid and extracorporeal membrane oxygenation.
Brumfield E; Bernard KR; Kabrhel C
Am J Emerg Med; 2015 Dec; 33(12):1840.e3-5. PubMed ID: 25921969
[TBL] [Abstract][Full Text] [Related]
12. What are the adverse effects associated with the combined use of intravenous lipid emulsion and extracorporeal membrane oxygenation in the poisoned patient?
Lee HM; Archer JR; Dargan PI; Wood DM
Clin Toxicol (Phila); 2015 Mar; 53(3):145-50. PubMed ID: 25634667
[TBL] [Abstract][Full Text] [Related]
13. [The use of extracorporeal life support and continuous venovenous haemodiafiltration in severe angiotensin converting enzyme inhibitor, calcium channel bloker and beta-blocker multidrug intoxication].
Stycuła W; Borówka M; Jarosz J; Kołcz J; Skalski J
Przegl Lek; 2013; 70(11):993-6. PubMed ID: 24697046
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal membrane oxygenation support for cardiac dysfunction from tricyclic antidepressant overdose.
Goodwin DA; Lally KP; Null DM
Crit Care Med; 1993 Apr; 21(4):625-7. PubMed ID: 8472584
[No Abstract] [Full Text] [Related]
15. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
Hicks JK; Sangkuhl K; Swen JJ; Ellingrod VL; Müller DJ; Shimoda K; Bishop JR; Kharasch ED; Skaar TC; Gaedigk A; Dunnenberger HM; Klein TE; Caudle KE; Stingl JC
Clin Pharmacol Ther; 2017 Jul; 102(1):37-44. PubMed ID: 27997040
[No Abstract] [Full Text] [Related]
16. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update.
Scott SA; Sangkuhl K; Stein CM; Hulot JS; Mega JL; Roden DM; Klein TE; Sabatine MS; Johnson JA; Shuldiner AR;
Clin Pharmacol Ther; 2013 Sep; 94(3):317-23. PubMed ID: 23698643
[TBL] [Abstract][Full Text] [Related]
17. CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial.
Mosley SA; Cicali E; Del Cueto A; Portman DG; Donovan KA; Gong Y; Langaee T; Gopalan P; Schmit J; Starr JS; Silver N; Chang YD; Rajasekhara S; Smith JE; Soares HP; Clare-Salzler M; Starostik P; George TJ; McLeod HL; Fillingim RB; Hicks JK; Cavallari LH
Pharmacotherapy; 2023 Dec; 43(12):1286-1296. PubMed ID: 37698371
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study.
Agulló L; Aguado I; Muriel J; Margarit C; Gómez A; Escorial M; Sánchez A; Fernández A; Peiró AM
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445931
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal cardio-pulmonary resuscitation in poisoning: A scoping review article.
Ng M; Wong ZY; Ponampalam R
Resusc Plus; 2023 Mar; 13():100367. PubMed ID: 36860990
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
